Platte River Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.68M Hold
20,105
0.45% 41
2024
Q2
$1.55M Hold
20,105
0.43% 41
2024
Q1
$1.38M Hold
20,105
0.39% 44
2023
Q4
$1.16M Hold
20,105
0.38% 49
2023
Q3
$1.06M Hold
20,105
0.39% 45
2023
Q2
$1.09M Hold
20,105
0.38% 45
2023
Q1
$1.01M Hold
20,105
0.39% 47
2022
Q4
$930K Hold
20,105
0.39% 47
2022
Q3
$779K Hold
20,105
0.35% 51
2022
Q2
$749K Hold
20,105
0.32% 53
2022
Q1
$890K Sell
20,105
-1,445
-7% -$62.6K 0.32% 52
2021
Q4
$935K Sell
21,550
-330
-2% -$13.9K 0.32% 53
2021
Q3
$949K Hold
21,880
0.35% 50
2021
Q2
$936K Hold
21,880
0.36% 51
2021
Q1
$847K Hold
21,880
0.35% 52
2020
Q4
$821K Buy
21,880
+490
+2% +$17.7K 0.35% 52
2020
Q3
$817K Sell
21,390
-3,120
-13% -$120K 0.42% 51
2020
Q2
$872K Buy
+24,510
New +$883K 0.48% 52
2019
Q4
$1.09M Buy
+26,020
New +$1.09M 0.57% 45

Other funds holding BSX

Platte River Wealth Advisors's BSX Position: Q3 2024 in Review

Platte River Wealth Advisors held its Boston Scientific (BSX) position steady in Q3 2024 at 20,105 shares worth $1.68M. The position accounts for 0.45% of the portfolio, ranked #41.

Platte River Wealth Advisors first reported a position in BSX in Q4 2019 and has held it in 19 quarters since. 1,396 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Platte River Wealth Advisors held 20,105 shares of Boston Scientific worth $1.68M as of Q3 2024.
  • Platte River Wealth Advisors left its Boston Scientific share count unchanged in Q3 2024.
  • Boston Scientific made up 0.45% of Platte River Wealth Advisors's portfolio in Q3 2024, its #41 holding.
  • Platte River Wealth Advisors first reported a position in Boston Scientific in Q4 2019 and has held it in 19 quarters since.
  • 1,396 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Platte River Wealth Advisors's 13F filing for Q3 2024, filed 7 Oct 2024.